CircVAMP3: A circRNA with a Role in Alveolar Rhabdomyosarcoma Cell Cycle Progression.
AKT
alveolar rhabdomyosarcoma
cell cycle progression
circVAMP3
m6A
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
28 06 2021
28 06 2021
Historique:
received:
17
05
2021
revised:
15
06
2021
accepted:
23
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
2
2022
Statut:
epublish
Résumé
Circular RNAs (circRNAs), a class of covalently closed RNAs formed by a back-splicing reaction, have been involved in the regulation of diverse oncogenic processes. In this article we describe circVAMP3, a novel circular RNA overexpressed in RH4, a representative cell line of alveolar rhabdomyosarcoma. We demonstrated that circVAMP3 has a differential m
Identifiants
pubmed: 34203273
pii: genes12070985
doi: 10.3390/genes12070985
pmc: PMC8303801
pii:
doi:
Substances chimiques
RNA, Circular
0
RNA
63231-63-0
Oncogene Protein v-akt
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Mol Cell. 2017 Apr 6;66(1):22-37.e9
pubmed: 28344082
Cancer Cell. 2011 Feb 15;19(2):157-9
pubmed: 21316595
Cell. 2016 Apr 7;165(2):289-302
pubmed: 27040497
Nucleic Acids Res. 2016 Apr 7;44(6):2846-58
pubmed: 26861625
J Hematol Oncol. 2019 Sep 4;12(1):90
pubmed: 31484561
Adolesc Health Med Ther. 2014 Jun 17;5:115-25
pubmed: 24966711
Nucleic Acids Res. 2020 Jan 8;48(D1):D682-D688
pubmed: 31691826
Nature. 2013 Mar 21;495(7441):333-8
pubmed: 23446348
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Mol Med (Berl). 2017 Nov;95(11):1179-1189
pubmed: 28842720
Nat Rev Dis Primers. 2019 Jan 7;5(1):1
pubmed: 30617281
Cell Rep. 2020 May 12;31(6):107641
pubmed: 32402287
Nat Methods. 2015 Aug;12(8):767-72
pubmed: 26121403
J Oncol. 2012;2012:951724
pubmed: 22481935
Nat Struct Mol Biol. 2015 Mar;22(3):256-64
pubmed: 25664725
Science. 2017 Sep 22;357(6357):
pubmed: 28798046
Front Oncol. 2013 Jul 17;3:183
pubmed: 23882450
Development. 2020 Aug 24;147(16):
pubmed: 32839270
Nat Rev Cancer. 2015 Jul;15(7):426-39
pubmed: 26105539
Cell Rep. 2015 Jan 6;10(1):103-11
pubmed: 25543144
Oncogene. 2019 May;38(20):3843-3854
pubmed: 30670781
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nat Commun. 2016 Apr 06;7:11215
pubmed: 27050392
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Cell Res. 2017 May;27(5):626-641
pubmed: 28281539
Mol Cell. 2015 Jun 4;58(5):870-85
pubmed: 25921068
J Cell Biol. 2000 May 1;149(3):697-706
pubmed: 10791982
Oncogene. 2018 Jul;37(30):4055-4057
pubmed: 29706655
RNA. 2013 Feb;19(2):141-57
pubmed: 23249747
Brief Bioinform. 2018 Sep 28;19(5):803-810
pubmed: 28334140
Mol Cell. 2017 Apr 6;66(1):9-21.e7
pubmed: 28344080
PLoS One. 2014 Mar 07;9(6):e90859
pubmed: 24609083
Nat Commun. 2016 Aug 19;7:12429
pubmed: 27539542
Mol Ther Nucleic Acids. 2019 Jun 7;16:118-129
pubmed: 30861414